Metraipolis › archive › dc_5b81ebc08cd3
Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41156163
- DOI
- 10.3390/jcm14207293
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:58:49.579Z
- SHA-256 of the archived text
88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221- Stable URL of this page
https://metraipolis.com/documento/dc_5b81ebc08cd3
How to cite
Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163 — Europe PMC (en), https://europepmc.org/article/MED/41156163 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_5b81ebc08cd3 (Metraipolis archive dc_5b81ebc08cd3, sha256 88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221)
BibTeX
@misc{dc5b81ebc08cd3,
title = {Super Responders in Plaque Psoriasis: A Real-World, Multi-Agent Analysis Showing Bimekizumab Associated with the Highest Odds of PASI = 0 at Week 12 — Europe PMC PMID:41156163},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41156163},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_5b81ebc08cd3; sha256 88f418c39be966af1a53db8f18d6bf70519b343ed11b6e6704a37d2e7a599221},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41156163. Agents can read the archived copy with the MCP tool read_document.